Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Jacobs

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the California Dental Association|October 27, 2017
Life Outside the Operatory and Dental EthicsKenneth Jacobs
Journal of Bioethical Inquiry|October 21, 2016
GratefulKenneth Jacobs
The American Surgeon|August 7, 2007
Central venous sampling for intraoperative parathyroid hormone monitoring: are peripheral guidelines applicable?James T Broome, Jason J Schrager, Dean Bilheimer, et al.
Innovations (Philadelphia, Pa.)|January 28, 2017
Noninvasive Quantification of Blood Flow in Epicardial Coronary Arteries, Coronary Artery Bypass Grafts, and AnastomosesT Bruce Ferguson, Cheng Chen, Sunghan Kim, et al.
Annals of Surgical Oncology|October 16, 2010
Changing intraoperative parathyroid hormone collection sites from peripheral to central does not affect predictive accuracy during minimally invasive parathyroidectomySherif R Z Abdel-Misih, James T Broome, Xiaobai Li, et al.
Haematologica|July 20, 2023
Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemiaIbrahim Aldoss, Parastou Tizro, Davsheen Bedi, et al.
Research Square|August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialArmin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
Blood|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignanciesArmin Ghobadi, Ibrahim Aldoss, Shannon L Maude, et al.
Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the California Dental Association|October 27, 2017
Life Outside the Operatory and Dental EthicsKenneth Jacobs
Journal of Bioethical Inquiry|October 21, 2016
GratefulKenneth Jacobs
The American Surgeon|August 7, 2007
Central venous sampling for intraoperative parathyroid hormone monitoring: are peripheral guidelines applicable?James T Broome, Jason J Schrager, Dean Bilheimer, et al.
Innovations (Philadelphia, Pa.)|January 28, 2017
Noninvasive Quantification of Blood Flow in Epicardial Coronary Arteries, Coronary Artery Bypass Grafts, and AnastomosesT Bruce Ferguson, Cheng Chen, Sunghan Kim, et al.
Annals of Surgical Oncology|October 16, 2010
Changing intraoperative parathyroid hormone collection sites from peripheral to central does not affect predictive accuracy during minimally invasive parathyroidectomySherif R Z Abdel-Misih, James T Broome, Xiaobai Li, et al.
Haematologica|July 20, 2023
Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemiaIbrahim Aldoss, Parastou Tizro, Davsheen Bedi, et al.
Research Square|August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialArmin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
Blood|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignanciesArmin Ghobadi, Ibrahim Aldoss, Shannon L Maude, et al.
Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.
Pageof 1